Pediatric IVIG Therapy for Children

IVIG stands for intravenous immunoglobulin, a treatment made from purified antibodies collected from donated human plasma. These antibodies are administered through an IV and can be used to support the immune system or modify abnormal immune activity in certain medical conditions.

IVIG is used in both adults and children, although the specific indication, product, dose, frequency, and duration of treatment depend on the child’s diagnosis and physician’s treatment plan.

Several IVIG products are FDA-approved for certain pediatric uses. For example, some immune globulin products are approved for primary humoral immunodeficiency in children age two and older, and certain products also have pediatric indications for immune thrombocytopenia.

Because IVIG products have different FDA-approved indications and age ranges, a child’s treating physician and pharmacy team determine which therapy is clinically appropriate.

Pediatric IVIG may be prescribed for certain immune, hematologic, neurologic, or inflammatory conditions.

Examples can include:

• Primary immunodeficiency disorders
• Certain antibody deficiencies
• Immune thrombocytopenia, or ITP
• Kawasaki disease
• Certain neurologic or autoimmune disorders
• Other physician-directed indications where immunoglobulin therapy may be appropriate

IVIG has established pediatric uses in primary immunodeficiency and selected immune-mediated conditions, while some pediatric uses may be off-label depending on the diagnosis and product prescribed.

Mercy Infusion does not determine whether a child should receive IVIG. Treatment must be prescribed and directed by the child’s physician.

Primary immunodeficiency disorders can make it more difficult for a child’s immune system to produce adequate antibodies.

For some children, IVIG provides replacement antibodies that help support immune function.

FDA-approved IVIG products for pediatric primary humoral immunodeficiency include products indicated for patients age two and older.

The frequency of therapy varies by product and treatment plan. Some children may receive IVIG at regular intervals as part of ongoing immune replacement therapy.

Learn more about IVIG therapy.

Immune thrombocytopenia, commonly called ITP, is a condition in which the immune system contributes to a reduced platelet count.

Certain IVIG products are approved for use in children with ITP. For example, GAMUNEX-C includes ITP among its indications for adults and children.

Whether IVIG is appropriate depends on factors such as platelet count, symptoms, bleeding risk, and the child’s overall clinical situation.

IVIG is also used by specialists in selected pediatric neurologic, rheumatologic, dermatologic, and inflammatory conditions.

Published pediatric reviews describe IVIG use in conditions such as Guillain-Barré syndrome, inflammatory myopathies, myasthenia gravis, Kawasaki disease, and other immune-mediated disorders. However, not every use is FDA-approved, and treatment decisions must be individualized by the child’s specialist.

This distinction is important because IVIG is not one standard treatment for every child or every diagnosis.

Before an infusion begins, the care team reviews the child’s physician order and treatment plan.

Depending on the specific prescription and setting, the process may include:

• Reviewing the child’s medication and medical history
• Confirming the prescribed IVIG product and dose
• Checking baseline vital signs
• Establishing or accessing IV access
• Beginning the infusion at the prescribed rate
• Monitoring the child throughout treatment
• Adjusting the infusion rate when clinically appropriate
• Providing post-infusion instructions to the parent or caregiver

Infusion time can vary substantially depending on the child’s weight, prescribed dose, IVIG product, infusion rate, treatment history, and tolerance.

Families should follow the specific instructions provided by the treating physician and infusion team.

In some cases, pediatric IVIG home infusion may be an option.

Eligibility depends on several factors, including:

• The child’s diagnosis
• Physician order
• Medical stability
• Previous treatment history
• IV access needs
• Product and dosing requirements
• Ability to safely monitor the infusion
• Insurance authorization
• Home environment
• Availability of appropriately trained nursing support

Home infusion is not appropriate for every pediatric patient.

For eligible children, however, receiving treatment at home may help reduce travel and allow the child to remain in a familiar environment.

Learn more about home infusion therapy.

For families whose children qualify for home therapy, potential advantages may include:

Familiar surroundings

Children may feel more comfortable receiving treatment at home rather than traveling to a medical facility.

Less travel

Recurring infusion appointments can create significant transportation demands for families.

More convenient scheduling

Home infusion may make it easier to coordinate treatment around school, work, and family schedules.

One-on-one nursing attention

Home infusion typically allows the nurse to focus directly on the child during treatment.

Reduced disruption

For children who receive recurring IVIG, home treatment may help make therapy a more manageable part of the family’s routine.

These benefits do not mean home infusion is the right option for every child. The physician, pharmacy, nursing team, and insurer all play a role in determining whether home treatment is appropriate.

Some pediatric patients may be better suited for treatment in an infusion suite or other supervised medical setting.

This may be recommended when:

• A child is receiving an initial infusion
• More intensive observation is required
• There is a history of significant infusion reactions
• The child has complex medical needs
• The physician prefers a clinical setting
• Home treatment is not authorized by insurance

Mercy Infusion can help coordinate the appropriate treatment setting based on the physician’s order and clinical requirements.

Learn more about our infusion suite.

IVIG has been used for decades in pediatric and adult patients, but like any medical therapy, it can cause side effects.

Possible infusion-related effects can include:

• Headache
• Fatigue
• Chills
• Fever
• Nausea
• Flushing
• Muscle aches
• Changes in blood pressure
• Infusion-site discomfort

More serious complications are possible and vary based on the IVIG product and individual risk factors.

FDA prescribing information for IVIG products includes warnings concerning risks such as thrombosis and kidney dysfunction, among others.

Parents and caregivers should discuss the child’s medical history and risk factors with the treating physician before therapy begins.

Preparation often depends on the child’s age and previous experience with medical care.

Families may find it helpful to:

• Explain the treatment in age-appropriate language
• Bring a favorite toy, book, tablet, blanket, or activity
• Dress the child in comfortable clothing
• Follow the care team’s hydration instructions
• Bring a list of medications and allergies
• Tell the nurse about previous infusion reactions
• Ask questions before treatment begins

Parents should follow the physician’s and infusion team’s instructions regarding hydration, medications, and premedication.

There is no single infusion time for all pediatric patients.

The length of an IVIG infusion depends on:

• Child’s weight
• Prescribed dose
• IVIG product
• Starting infusion rate
• Maximum tolerated rate
• Previous infusion history
• Clinical condition
• Physician orders

Some treatments may take several hours.

The care team will provide an estimated treatment time based on the individual prescription.

That depends on why IVIG was prescribed.

Some conditions may require a limited course of therapy, while children with certain primary immunodeficiency disorders may receive ongoing immunoglobulin replacement therapy.

The child’s specialist determines:

• Dose
• Frequency
• Treatment duration
• Laboratory or clinical monitoring
• Whether therapy should continue or change

Families should not change or stop IVIG treatment without discussing it with the prescribing physician.

Coverage varies according to:

• Diagnosis
• Prescribed IVIG product
• Insurance plan
• Medical necessity requirements
• Treatment setting
• Prior authorization requirements
• Network status

Because IVIG can be a specialized and costly therapy, many insurers require prior authorization before treatment begins.

Mercy Infusion can work with the physician’s office and insurance carrier to help verify benefits and obtain required authorization.

Learn more about specialty pharmacy insurance and prior authorization.

For eligible patients, financial assistance may be available through manufacturer programs, charitable foundations, or other resources.

Eligibility varies, and assistance is not guaranteed.

Mercy’s team can help families understand available options and determine whether they may qualify for applicable programs.

Learn more about financial assistance for specialty medications.

Managing specialty therapy for a child can involve more than simply receiving medication.

Mercy Infusion helps coordinate:

• Prescription processing
• Insurance benefit verification
• Prior authorization support
• Medication coordination
• Nursing services
• Infusion scheduling
• Patient and caregiver education
• Financial assistance resources when available
• Communication with the prescribing provider

Our goal is to help make the treatment process easier to navigate for families while supporting the physician-directed plan of care.

Mercy Infusion provides specialty pharmacy and infusion support for patients throughout California.

Our team works closely with patients, families, physicians, and insurance plans to help coordinate treatment from referral through ongoing therapy.

Families receive support from professionals experienced in specialty medications, infusion services, insurance authorization, and patient access.

Mercy Pharmacy Group also maintains URAC and ACHC accreditation, reflecting independent review of pharmacy and healthcare quality standards.

Learn more about URAC and ACHC accreditation.

What age can a child receive IVIG?

There is no universal minimum age for every IVIG treatment. Age eligibility depends on the condition being treated, the prescribed product, FDA labeling, and the physician’s clinical judgment. Several IVIG products are FDA-approved for certain indications in patients age two and older.

Can my child receive IVIG at home?

Possibly. Pediatric home IVIG depends on physician approval, the child’s medical stability, treatment history, nursing requirements, insurance authorization, and other clinical factors.

Does IVIG hurt?

IVIG is administered through an IV, so there may be discomfort when IV access is placed. The infusion itself generally should not be painful, although some children can experience infusion-related side effects.

How often will my child need IVIG?

Frequency depends on the diagnosis, prescribed product, dose, and physician-directed treatment plan.

Can parents stay with their child during treatment?

In most pediatric infusion settings, a parent or caregiver can remain with the child during treatment. Specific policies may vary by treatment location.

Is IVIG the same as a blood transfusion?

No. IVIG is a purified immunoglobulin product manufactured from donated human plasma. It is not the same as receiving whole blood.

Does Mercy help with insurance authorization?

Yes. Mercy’s team can help verify benefits and coordinate prior authorization requirements with the physician’s office and insurance carrier. Coverage and authorization are ultimately determined by the insurance plan.

Talk With Mercy About Pediatric IVIG

If your child’s physician has prescribed IVIG or you are trying to understand treatment options, Mercy Infusion can help you navigate the next steps.

Our team can assist with insurance verification, prior authorization, medication coordination, nursing arrangements, and determining whether home infusion or another treatment setting may be appropriate.

Call Mercy Infusion at 833-594-0124

Or contact us through the website to learn more about pediatric IVIG therapy and infusion services.